Lisa May Ling Tachiki (Lisa Tachiki)

Years Active: 2018-2023
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Lisa May Ling Tachiki, Daniel S Hippe, Karly Williams Silva, Evan Thomas Hall, William McCamy, Dane Fritzsche, Andrea Perdue, Julia Majovski, Thomas Pulliam, Daniel A Goldstein, Joshua Veatch, Joel Ho, Paul T Nghiem, John A Thompson, Shailender Bhatia
Correction to: Extended duration of treatment using reduced‑frequency dosing of anti‑PD‑1 therapy in patients with advanced melanoma and Merkel cell carcinoma. Cancer immunology, immunotherapy : CII (2023)
Lisa May Ling Tachiki, Daniel S Hippe, Karly Williams Silva, Evan Thomas Hall, William McCamy, Dane Fritzsche, Andrea Perdue, Julia Majovski, Thomas Pulliam, Daniel A Goldstein, Joshua Veatch, Joel Ho, Paul T Nghiem, John A Thompson, Shailender Bhatia
Extended duration of treatment using reduced-frequency dosing of anti-PD-1 therapy in patients with advanced melanoma and Merkel cell carcinoma. Cancer immunology, immunotherapy : CII (2023)
Lisa May Ling Tachiki, Zhao Ming Dong, Nicholas Burwick
Atypical chronic lymphocytic leukemia presenting with massive IgM paraprotein. Annals of hematology 97 (5) (2018)

Lisa May Ling Tachiki.css-eqlu8i{font-size:small;padding-left:4px;} (Lisa Tachiki)